SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : RNAi
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: keokalani'nui who wrote (336)1/30/2005 7:18:15 PM
From: DewDiligence_on_SI   of 671
 
>>Hard to imagine any Acuity P1 results being so bad they will slam alny's stock, yet any positive proof of concept data would surely immediately spill over. So, why wait? <<

I would like to see some evidence of RNAi-based efficacy in AMD, and I rather doubt that Acuity’s results will have much of an effect on ALNY’s near-term stock price one way or the other. Regards, Dew

Talk biotech at www.tinyurl.com/zaqn
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News